Skip to main content
    M

    Minerva Neurosciences Inc (NERV)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.20
    -0.10 (-4.35%)

    Market Cap: $114.62M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Minerva Neurosciences Inc (NERV) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Minerva Neurosciences are Neumora Therapeutics (NMRA), NRX Pharmaceuticals (NRXP) and LENZ Therapeutics (LENZ). By market cap, Minerva Neurosciences ranks 7th of the 13 companies on this page; Zentalis Pharmaceuticals Llc (ZNTL) is the largest at $167.05M.

    Peer Comparison

    NERV's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Minerva Neurosciences (NERV)$114.62MN/AN/A0.0%N/A0.0%0.00%
    Neumora Therapeutics, Inc. (NMRA)$80.59MN/AN/A0.0%-260.5%0.0%0.00%
    NRX Pharmaceuticals Inc (NRXP)$95.58MN/A23.8x0.0%N/A0.0%0.00%
    LENZ Therapeutics Inc (LENZ)$129.77MN/A9.7x0.0%N/A-72.9%0.00%
    Voyager Therapeutics Inc (VYGR)$107.66MN/A4.0x0.0%N/A-70.0%0.00%
    Neuraxis, Inc. (NRXS)$76.93MN/A9.6x-144.4%-247.7%115.7%0.00%
    Immunic Inc (IMUX)$102.61MN/AN/A0.0%N/A0.0%0.00%
    Sionna Therapeutics, Inc. Common Stock (SION)$150.63MN/AN/A0.0%N/A0.0%0.00%
    Pmv Pharmaceuticals Inc (PMVP)$95.93MN/AN/A0.0%N/A0.0%0.00%
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)$141.66MN/AN/A0.0%N/A-100.0%0.00%
    Compass Therapeutics Inc. (CMPX)$139.35MN/AN/A0.0%N/A0.0%0.00%
    Zentalis Pharmaceuticals Llc (ZNTL)$167.05MN/AN/A0.0%N/A0.0%0.00%
    Cassava Sciences Inc (SAVA)$114.97MN/AN/A0.0%N/A0.0%0.00%
    Peer median$111.31MN/A9.7x0.0%-254.1%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Minerva Neurosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Neumora Therapeutics, Inc. (NMRA)
    Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases...
    NMRA competitors
    NRX Pharmaceuticals Inc (NRXP)
    NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company...
    NRXP competitors
    LENZ Therapeutics Inc (LENZ)
    LENZ Therapeutics Inc is a cutting-edge biopharmaceutical company dedicated to developing transformative therapies for neurological disorders...
    LENZ competitors
    Voyager Therapeutics Inc (VYGR)
    Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases.
    VYGR competitors
    Neuraxis, Inc. (NRXS)
    NeurAxis, Inc. is a neuromodulation therapy device company in the United States. The company is headquartered in Versailles, Indiana.
    NRXS competitors
    Immunic Inc (IMUX)
    Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune...
    IMUX competitors
    Sionna Therapeutics, Inc. Common Stock (SION)
    Sionna Therapeutics, Inc. is an innovative biotechnology company focused on developing advanced therapies for neurodegenerative disorders...
    SION competitors
    Pmv Pharmaceuticals Inc (PMVP)
    PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53...
    PMVP competitors
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
    NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy...
    NTHI competitors
    Compass Therapeutics Inc. (CMPX)
    Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple...
    CMPX competitors
    Zentalis Pharmaceuticals Llc (ZNTL)
    Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment...
    ZNTL competitors
    Cassava Sciences Inc (SAVA)
    Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.

    Frequently Asked Questions About NERV

    Who are Minerva Neurosciences' main competitors?

    The companies most similar to Minerva Neurosciences include Neumora Therapeutics (NMRA), NRX Pharmaceuticals (NRXP), LENZ Therapeutics (LENZ), Voyager Therapeutics (VYGR) and Neuraxis (NRXS), listed from the closest match.

    Who is Minerva Neurosciences' biggest competitor?

    Zentalis Pharmaceuticals Llc (ZNTL) is the largest of the similar companies at $167.05M; Neumora Therapeutics (NMRA) is the closest match by business profile, size, sector and industry.

    How does NERV stock compare with its competitors?

    NERV's net margin is 0.0% against a peer median of 0.0%.

    Which of Minerva Neurosciences' competitors pays a higher dividend?

    Minerva Neurosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Minerva Neurosciences bigger than its competitors?

    No. Minerva Neurosciences is 7th by market cap among the 13 companies on this page; the largest is Zentalis Pharmaceuticals Llc (ZNTL) at $167.05M.